Cargando…
Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic stimuli that may promote malignancy. To investigate whether the oncogenic nature of lipogenesis closely depends on the overexpression of HER2 protooncogene, the normal breast cell line, HB4a, was transfected wi...
Autores principales: | Ravacci, Graziela Rosa, Brentani, Maria Mitzi, Tortelli, Tharcisio Citrângulo, Torrinhas, Raquel Suzana M. M., Santos, Jéssica Reis, Logullo, Angela Flávia, Waitzberg, Dan Linetzky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659962/ https://www.ncbi.nlm.nih.gov/pubmed/26640797 http://dx.doi.org/10.1155/2015/838652 |
Ejemplares similares
-
Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study
por: Santos, Jéssica Reis, et al.
Publicado: (2020) -
Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass
por: Sala, Priscila, et al.
Publicado: (2017) -
α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways
por: Mason, Julie K., et al.
Publicado: (2015) -
Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
por: Fiszman, Gabriel L., et al.
Publicado: (2011) -
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
por: Natoli, Clara, et al.
Publicado: (2013)